This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Oct 12;130(15):1689-1690.

doi: 10.1182/blood-2017-08-800763.

Impacting inhibitor development in hemophilia A

Barbara A Konkle¹

Affiliations

PMID: 29025717
DOI: 10.1182/blood-2017-08-800763

Free article

Comment

Impacting inhibitor development in hemophilia A

Barbara A Konkle. Blood. 2017.

Free article

. 2017 Oct 12;130(15):1689-1690.

doi: 10.1182/blood-2017-08-800763.

Author

Barbara A Konkle¹

Affiliation

¹ BLOODWORKS NORTHWEST; UNIVERSITY OF WASHINGTON.

PMID: 29025717
DOI: 10.1182/blood-2017-08-800763

Erratum in

Konkle BA. Impacting inhibitor development in hemophilia A. Blood. 2017;130(15):1689-1690.
[No authors listed] [No authors listed] Blood. 2017 Dec 21;130(25):2809. doi: 10.1182/blood-2017-11-815100. Blood. 2017. PMID: 29269533 No abstract available.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

Comment on

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis.
Rosendaal FR, Palla R, Garagiola I, Mannucci PM, Peyvandi F; SIPPET Study Group. Rosendaal FR, et al. Blood. 2017 Oct 12;130(15):1757-1759. doi: 10.1182/blood-2017-06-791756. Epub 2017 Aug 2. Blood. 2017. PMID: 28768627 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science